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Abstract
Background: Nucleolus is the most prominent mammalian organelle within the nucleus which is also the site for
ribosomal biogenesis. There have been many reports indicating the involvement of nucleolus in the process of
aging. Several proteins related to aging have been shown to localize in the nucleolus, which suggests the role of
this organelle in senescence.
Results: In this study, we used quantitative mass spectrometry to map the flux of proteins into and out of the
nucleolus during the induction of senescence in cultured mammalian cells. Changes in the abundance of 344
nucleolar proteins in sodium butyrate-induced senescence in NIH3T3 cells were studied by SILAC (stable isotope
labeling by amino acids in cell culture)-based mass spectrometry. Biochemically, we have validated the proteomic
results and confirmed that B23 (nucleophosmin) protein was down-regulated, while poly (ADP-ribose) polymerase
(PARP) and nuclear DNA helicase II (NDH II/DHX9/RHA) were up-regulated in the nucleolus upon treatment with
sodium butyrate. Accumulation of chromatin in the nucleolus was also observed, by both proteomics and
microscopy, in sodium butyrate-treated cells. Similar observations were found in other models of senescence,
namely, in mitoxantrone- (MTX) treated cells and primary fibroblasts from the Lamin A knockout mice.
Conclusion: Our data indicate an extensive nuclear organization during senescence and suggest that the
redistribution of B23 protein and chromatin can be used as an important marker for senescence.
Background
Cellular senescence is an irreversible growth-arrest pro-
gramme that limits cell proliferation in an organism.
This process may contribute to physiological aging, a
complex phenomenon that involves the interplay of
multiple genetic and environmental factors, resulting in
the diminishing capacity of tissues to respond to stress
and injury [1,2]. Many experimental models have been
established for studying this fundamental process. Repli-
cative senescence is one of the most commonly used
model systems. Some of the morphological and molecu-
lar events in senescence can be reproduced by the
repeated passage of mammalian cells in tissue culture,
possibly due to telomere deprotection. Senescence can
be accelerated by subjecting cultured cells to chemical
or genotoxic stress, such as sodium butyrate [3,4], MTX
[5], irradiation [6,7] or by overexpressing the oncogenic
ras gene [8]. In addition, the contributions of specific
genes to the regulation of senescence have been studied
by using cell lines derived from patients of accelerated
aging diseases, such as Werner’s disease [9]. Finally,
transgenic animals have been created as models for
accelerated aging diseases [10,11]. For example, Lamin
A knockout mice manifest symptoms of pre-mature
aging diseases. Another lineo ft r a n s g e n i cm i c et h a t
lacked Zmpste24, an enzyme that aids in the maturation
of pre-lamin A to Lamin A, also demonstrate acceler-
ated aging phenotypes [12,13].
The association of mutatio n si nl a m i n sa n dl a m i n -
related proteins with accelerated aging phenotypes in
humans suggests the possible role of nuclear shape and
organization in the regulation of senescence. It is known
that the nuclear architecture changes during the natural
aging of wild-type Caenorhabditis elegans [14]. Major
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of senescence-associated heterochromatin foci (SAHF),
have also been observed in cultured human fibroblasts
when senescence was induced by overexpressing the ras
oncogene [15]. Apart from the nuclear envelope and
chromatin, the most common cellular orgenelle asso-
ciated with aging is the nucleolus. Many of the proteins
mutated in human premature aging syndromes [9] are
localized in the nucleolus at least during part of the cell
cycle or under some other conditions. For example, the
wild-type Werner syndrome protein is partially localized
in the nucleoli, where it may be involved in rDNA tran-
scription [16]. Similarly, the Cockayne syndrome B
(CSB) protein is also nucleolar [17]. The BLM protein,
mutated in the Bloom syndrome, is present in the
nucleolus during the S phase [18], while the Rothmund-
Thomson disease protein RecQL4 accumulates in the
nucleolus during oxidative stress [19]. In addition, dys-
kerin, a protein mutated in the premature aging disease,
dyskeratosis congenital, is associated with snoRNAs [20]
and telomerase RNA, are also localized in the nucleoli
and Cajal bodies [21]. The intranuclear localization of
these proteins hint at the possible role of the nucleolus
in aging in response to cumulative stress sustained by
cells over time, or to the maintenance of the prolifera-
tive capacity of stem cells essential for tissue repair.
A more direct demonstration of the role of nucleoli in
aging comes from observations in which some muta-
tions in budding yeast can lead to an extension in life
span [22]. For example, cells with mutations in the SIR4
gene can live for 50% longer. SIR4 encodes a protein
that exists in a complex with Sir2p and Sir3p, which is
linked with transcriptional silencing. Remarkably, Sir3p
is localized at the telomeres and HM loci in young yeast
cells, but relocate to the nucleolus in old cells. Further-
more, life-extending mutations of SIR4 can also cause
the SIR2/3/4p complex to accumulate in the nucleolus.
These findings show that, at least in yeast, the composi-
tion of nucleoli changes as the cell ages, and that these
changes are functionally linked to the control of life-
span. The redistribution of Sir protein from telomeres
to nucleoli as yeast ages is echoed by the detection of
telomeric components in mammalian nucleoli. Tomlin-
son et al. [23] examined the intracellular distribution of
telomerase RNA and telomerase reverse transcriptase in
HeLa cells, and reported their localization in nucleoli
and Cajal bodies during the S phase, which implicates
that both these structures are involved in the biogenesis
and trafficking of telomerase. Telomerase can also inter-
act with nucleolin [24], an abundant multi-functional
nucleolar protein. In mammalian cells, telomere short-
ening initiates senescence by activating p53, the central
regulator of cellular stress responses, and thereby signal-
ling to the cell cycle checkpoint pathways, which are
also activated by DNA damage [25]. The nucleolus once
again plays a crucial role in regulating the activity and
stability of p53 [26]. The nucleolar protein ARF regu-
lates the ubiquitination and degradation of p53. Other
p53 interacting proteins, such as nucleostemin [27], and
ING1b [28] are also found in the nucleoli, which sug-
gests that nucleolar targeting of p53-regulating proteins
is a common mechanism for the activation of p53 and
hence, all p53-related pathways. Notably, nucleostemin
is a nucleolar GTP-binding protein highly enriched in
the stem cells and cancer cells, but absent in differen-
tiated cells [27]. Manipulation of nucleostemin expres-
sion levels leads to changes in senescent phenotypes of
mouse cells [27].
The nucleolus is the largest organelle in a mammalian
n u c l e u sa n dt h es i t eo fr i b o s omal subunit production.
Recent studies have revealed that nucleolus also plays a
significant role in other cellular functions. New techni-
ques for studying the nucleolus are starting to provide
insights into these non-conventional functions of this
organelle. The human nucleolus has been the subject of
some of the largest organellar proteomic efforts [29].
Almost 700 proteins have been characterized, and out of
which at present time about 30% are uncharacterized
genes. SILAC-based quantitative mass spectrometry has
been successfully applied to study the effect of transcrip-
tion inhibition on the protein composition of the
nucleolus [30]. More recently, this technique has been
used to study the effect of viral infections on HeLa cell
nucleolar proteome [31]. In this study, we used this high
throughput quantitative mass spectrometry-based
approach to map global changes in nucleolar proteome
in stress induced senescent cells and provide for the
first time, a biochemical snapshot of this organelle in
senescent mouse fibroblast cells.
Methods
Cell culture
The mouse fibroblast cell line, NIH3T3 cells and pri-
mary mouse fibroblast cells were grown in Dulbecco’s
Modified Eagle Medium (DMEM) (GIBCO, Invitrogen,
USA) supplemented with 10% FBS with Anti-anti (100
units/ml) (GIBCO, Invitrogen, USA), maintained at 37°
C, 95% humidity, and 5% carbon dioxide.
Reagents and antibodies
Sodium butyrate and MTX were purchased from Sigma-
Aldrich. A 2 M stock solution of sodium butyrate was
made in distilled water and stored at 4°C. A 2 mM
s t o c ks o l u t i o no fM T Xw a sm a d ei ne t h a n o la n ds t o r e d
at 4°C. Antibodies for fibrillarin (H-140), PARP (H-300)
and NDHII (H-300) were purchased from Santa Cruz
Biotechnology. The antibodies for B23 and actin were
purchased from Sigma-Aldrich. A fluorescence
kar et al. BMC Cell Biology 2011, 12:33
http://www.biomedcentral.com/1471-2121/12/33
Page 2 of 13conjugated secondary antibody (anti-mouse Ig -TRITC)
was purchased from Jackson Immunologicals. Anti-
mouse-HRP and Anti-rabbit-HRP were purchased from
GE Healthcare. A Novex colloidal blue staining kit was
purchased from Invitrogen for staining protein bands
with coomasie blue on sodium dodecyl sulfate polyacry-
lamide gel electrophoresis (SDS-PAGE) gel.
Senescence associated (SA) b-galactosidase staining
A senescence b-galactosidase staining kit was purchased
from Cell Signaling Technology. NIH3T3 cells were
seeded on a six-well tissue culture dish, and the next
day, treated with 5 mM sodium butyrate. Following 4
days of treatment with sodium butyrate, the cells were
stained with b-gal according to the manufacturer’sp r o -
tocol. The cells were then monitored for blue coloration
under a microscope.
Immunostaining and microscopy
For indirect immunofluorescence, the cells were cul-
tured on coverslips that were sterilized by dipping into
100% ethanol followed by flaming. The cells were fixed
with 4% paraformaldehyde in PBS for 30 min at room
temperature and then permeabilized with 0.2% Triton
X-100 in PBS for 5 min at room temperature, washed in
PBS, and blocked with 50 mM glycine in PBS for 10
min. The coverslips were washed and incubated in
either a wash buffer (control) or primary antibody at a
dilution of 1:100-1:400 for 1 h at room temperature and
then washed three times in PBS and stained with a
fluorescence-conjugated secondary antibody at a con-
centration of 1:100 (Jackson Immunologicals) for 1 h at
room temperature and counter-stained with Hoechst
33258 (Sigma). The coverslips were mounted on a glass
slide in a fluorescent mounting medium (Dako). Images
were captured with a confocal microscope (Leica TCS
SPE).
5-Fluorouridine incorporation
In situ assay of RNA synthesis by 5-Fluorourdine (5-FU)
incorporation was performed as described [32]. Briefly,
5-FU (Sigma-Aldrich) was added to the culture medium
to a final concentration of 1 mM. After an incubation in
normal tissue culture conditions for 10 minutes, the
cells were washed in PBS and fixed in 1% paraformalde-
hyde (room temperature, 5 min) and then permeabilized
with 0.5% Triton X-100 in PBS for 5 min at room tem-
perature. The incorporated 5-FU was detected by anti-
BrU antibody (1:500, Sigma B2531) and fluorescence-
conjugated secondary antibody as described above.
Immunoblotting
The protein samples were separated with NuPAGE 12%
Bis-Tris gels (Invitrogen). Western blotting was
performed following a protein transfer from NuPAGE
gel to polyvinylidene difluoride (PVDF) membranes
(Millipore). Blots were blocked in a 5% nonfat dry milk
solution made up in PBS. The blots were subsequently
incubated with the appropriate primary antisera for 1 h
at room temperature. The membranes were washed
three times for 10 min each time in a PBS solution that
contained 0.05% Tween-20 solution. Subsequently, sec-
ondary antibodies conjugated to a horseradish peroxi-
dase (GE Healthcare) were added and incubated at
room temperature for 1 h. The blots were developed
with an enhanced chemiluminescence kit (GE
Healthcare).
FACS analysis
Cells (5 × 10
5) were harvested by trypsinization, washed
in PBS (200 g, 2 mins) and fixed in 70% ice-cold ethanol
for 1 h at 4°C. Following fixation, the cells were washed
in PBS twice and re-suspended in 500 μLo fs t a i n i n g
solution (10 μg/mL RNase A and 50 μg/mL propidium
iodide in PBS). The tubes were incubated for 30 min at
4°C in the dark. The DNA content was analyzed by a
flow cytometry (BD Calibur) and the percentage of cells
in different phases of the cell cycle was assessed by
using ModFit V 3.0 software.
Nucleolar isolation
Nucleolar isolation was performed according to the pub-
lished protocol with the following modifications for
NIH3T3 cells http://www.lamondlab.com/f7nucleolar-
protocol.htm. The NIH3T3 cells were dounce homoge-
nized 50 times which is enough to break open the
plasma membrane without disrupting the nucleus. We
sonicated the isolated nuclei for 12 × 10 sec at ampli-
tude of 30% (Cole-Parmer Instruments) to break open
the nuclear membrane without disrupting the nucleolus.
SILAC labeling and mass spectrometry
For SILAC labeling, prior to nucleolar isolation, all cells
were metabolically labeled by growing five rounds of
cell divisions in a SILAC DMEM medium supplemented
with 10% dialysed fetal calf serum (Biowest) to ensure
all the cellular proteins were labeled to saturation. All
isotopically labeled amino acids were purchased from
Cambridge Isotope Lab. Untreated control cells were
labeled with DMEM that contained L-13C6-arginine
(R6) and L-4,4,5,5-D4-lysine (K4), whereas sodium buty-
rate-treated cells were cultured in DMEM that con-
tained L-arginine (R0) and L-lysine (K0).
Protein amounts of nucleolar lysates were estimated
by a Bradford assay (Pierce). Nucleolar protein fractions
from control and treated cell sw e r em i x e da ta1 : 1p r o -
tein amount. The combined protein sample was sepa-
rated by electrophoresis as above. The gel was then
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stained with colloidal coomassie blue (Invitrogen)
according to the manufacturer’si n s t r u c t i o n s .T h eg e l
lane was cut into 15 slices. The gel slices were destained
with a destaining solution (Trypsin Profile IGD kit from
Sigma) according to the manufacturer’s instructions, fol-
l o w e db yi n c u b a t i o ni n5 0m Ma m m o n i u mb i c a r b o n a t e
that contained proteomic grade Trypsin (Sigma) (50 ng/
gel slice) overnight at 37°C. The resulting peptides were
extracted from each gel slice, analyzed by LC-MS on an
LTQ-Orbitrap mass spectrometer system (ThermoElec-
tron) coupled to a Dionex 3000 nano-LC system (Cam-
berley). The peptide mixture was loaded onto an LC-
Packings PepMap C18 column trap column (0.3 × 5
mm) equilibrated in 0.1% TFA in water at 20 μl/min,
and washed for 3 min at the same flow rate, and then
the trap column was switched in-line with an LC-Pack-
i n g sP e p M a pC 1 8c o l u m n( 0 . 0 7 5×1 5 0m m )e q u i l i -
brated in 0.1% formic acid/water. The peptides were
separated with a 55-min discontinuous gradient of acet-
onitrile/0.1% formic acid (2-40% acetonitrile for 40 min)
at a flow rate of 300 nl/min and the HPLC was inter-
faced to the mass spectrometer with an FS360-20-10
picotip (New Objective) fitted to a nanospray 1 interface
(ThermoElectron) with a voltage of 1.1 kV applied to
the liquid junction.
The Orbitrap was set to analyze the survey scans at
60,000 resolution and the top five ions in each duty
cycle selected for MS/MS in the LTQ linear ion trap.
The raw files were processed to generate a Mascot gen-
eric file by using the program Raw2msm [33] and
searched against the UniProt human database by using
the Mascot search engine v.2.2 (Matrix Science) run on
an in-house server with the following criteria; peptide
tolerance = 10 ppm, trypsin as the enzyme and carbox-
yamidomethylation of cysteine as a fixed modification.
Variable modifications were the oxidation of methio-
nine, and appropriate SILAC labels. Proteins with a total
Mascot peptide scores below 35 were ignored, based on
the decoy reversed database searching.
Quantitation was performed by using the program MS-
Quant http://msquant.sourceforge.net, with peptide ratios
calculated for each arginine- and/or lysine-containing pep-
tide as the peak area of labeled arginine/lysine divided by
the peak area of nonlabeled arginine/lysine for each sin-
gle-scan mass spectrum. Peptide ratios for all arginine-
and lysine-containing peptides sequenced for each protein
were averaged. MS-Quant measures the SILAC ratio of
each peptide throughout the elution of the ion pairs [34],
generating an averaged ratio for the identified peptide.
Standard deviations of the averaged protein ratios estimate
the variability of measured SILAC ratios for all the
detected peptides for each protein. Individual spectra were
inspected by using QualBrowser software (XCalibur;
ThermoElectron). ProteinCenter (Proxeon Bioinformatics)
proteomics data mining and management software was
used to eliminate redundancy and compare datasets, and
convert protein IDs to gene symbols and perform initial
gene ontology characterization.
Results and Discussion
Sodium butyrate induces senescence in NIH3T3 cells
We used sodium butyrate treatment of NIH3T3 cells as
a model system to study the effect of senescence on
nucleolar proteome in mammalian cells [4]. Following
treatment with 5 mM sodium butyrate for 4 days,
NIH3T3 cells adopted a flattened morphology with
spread-out cytoplasms, large nuclei (arrows, Figure 1A)
and in many cases, the cells were multinucleated. The
treated cells grew at a slower rate than the control cells,
but with little or no discernible cell death (data not
shown). A flow cytometry analysis showed that the trea-
ted cells are blocked in the G0/G1 phase of the cell
cycle with a reduced S-phase population (Figures 1B, C).
To confirm that the phenotypes we observed were
results of chemically induced senescence, but not phar-
macological cell cycle blockage, we performed a senes-
cence associated (SA)-b-gal assay on the sodium
butyrate-treated and mock-treated cells. SA-b-gal assay
measures the activity of b- galactosidase, a widely used
biomarker for senescent cells [35]. As shown in Figure
1D, the NIH3T3 cells show blue coloration (arrows, Fig-
ure 1D) after 4 days of sodium butyrate treatment,
whereas control cells are unstained. Taken together,
sodium butyrate induces senescence in NIH3T3 cells.
Isolation of nucleolus from normal and senescent NIH3T3
cells
To study the changes in the nucleolar protein composition
following senescence induction in NIH3T3 cells, we per-
formed SILAC-based quantitative proteomics on nucleoli
isolated from mock and sodium butyrate treated cells. In
this approach, a population of NIH3T3 cells were cultured
in a medium that contained heavy isotope-labeled arginine
and lysine (R6K4, see experimental procedure), and
another population in the same medium, except that the
arginine and lysine were not isotopically labeled (R0K0).
To ensure complete labeling, the cells were first cultured
in these media for 3 days, and then for the next four days,
they were either mock treated (R6K4) or sodium butyrate
treated (R0K0) while still in their respective labeled media
(Figure 2A). There was no observable effect of the use of
SILAC media on cell growth and responses to sodium
butyrate (data not shown). Following the treatment,
nucleoli were isolated from four 15 cm dishes of treated
cells and the same number of untreated control by using
an established protocol. The nuclei were first isolated
from the cells, and the nucleoli were released from the
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plasmic fraction by a sucrose cushion. A microscopy ana-
lysis of the isolated nuclei and nucleoli (Additional file 1,
A) demonstrated the intactness and purity of these frac-
tions. A Western blotting analysis of the cytosolic, nucleo-
p l a s m i ca n dt h en u c l e o l a rl y s a t e sw i t ha n t i b o d i e sf o r
fibrillarin (nucleolar marker), Lamin A/C (nucleoplasmic
marker) and actin (cytoplasmic marker) confirmed the
purity of that of the respective subcellular fractions (Addi-
tional file 1, B). Equal amounts of proteins from nucleoli
isolated from control and butyrate-treated cells were
mixed, separated by SDS-PAGE, and in-gel digested by
trypsin (Figure 2B). The resulting peptides were analyzed
by nano-ESI-LC-MS/MS.
The nucleolar proteome during senescence
We have identified and quantified a relative abundance of
344 proteins from a proteomic comparison of the senes-
cent and control nucleoli (Figures 2C and 2D, Additional
file, 2). The proteomic analysis indicated that the detected
proteins in mouse NIH3T3 nucleoli cover a similar func-
tional spectrum as the human nucleolar proteomes
previously reported [36,37]. This confirms the strong con-
servation of the compositions and functions of the nucleo-
lus [38]. The response of the nucleolar proteome to
chemically induced senescence is highly distinct from that
of other perturbations [30,31]. With some notable excep-
tions, most nucleolar proteins appear to be depleted from
the nucleolus as a result of transcriptional inhibition by
actinomycin D treatment [30]. In sodium butyrate treated
NIH3T3 cells, however, there is an overall accumulation
of proteins in the nucleolus, with only a small subset of
proteins found to be down-regulated following the treat-
ment (Figure 2C). This observation demonstrates the
remarkable plasticity of the nucleolus, which responds dif-
ferently to distinct metabolic conditions. For example,
ribosomal proteins are shown to accumulate in the
nucleolus of sodium butyrate treated cells (Figure 2E), but
depleted from the nucleolus in actinomycin D treated cells
whereas in adenoviral infected cells, the abundance of
ribosomal proteins in the nucleolus is largely unaffected
[31]. Interestingly, many proteins related to ribosomal bio-
genesis, such as Pop1, RrP15, Rrp12, BAP28, are depleted
from the nucleolus after sodium butyrate treatment. The
Figure 1 Induction of senescence in NIH3T3 cells following sodium butyrate treatment (A) NIH3T3 cell was treated with 5 mM of
sodium butyrate for 4 days and the morphological changes were monitored under a microscope. The bar represents 10 μm. (B) A FACS
analysis of the control and treated NIH3T3 cells followed by propidium iodide staining to analyze the cell cycle progression. Percentage of
untreated or sodium butyrate treated NIH3T3 cells in different phases of the cell cycle analyzed by using ModFit V 3.0 software. (C) A graphical
representation of the percentage of cells in different cell cycle phases in control and Sodium Butyrate treated cells as determined by propidium
iodide staining and followed by FACS analysis. (D) SA-b-gal staining of the control and sodium butyrate treated NIH3T3 cells following 4 days of
treatment. Blue coloration in cells indicates senescence.
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biogenesis factors suggest a possible shift in the kinetics of
ribosome assembly in senescent cells. Histones and chro-
matin remodeling factors, such as CHD5, RBBP4, and
CHD4, also dramatically accumulate in the nucleolus
upon treatment with sodium butyrate, which implies a
major change of chromatin organization in the nucleolus
during senescence (Figure 2E). Taken together, our quan-
titative proteomic analysis offers a unique overview of the
biochemical impact of chemically induced senescence on
the nucleolus.
Biochemical Validation of the Proteomic results from
Mass spectrometry
We selected three proteins identified by proteomic analy-
sis out of 344 proteins that were shown to change in
abundance in nucleoli in sodium butyrate treated cells,
and validated the SILAC results by traditional techniques.
Following sodium butyrate induced senescence, the
nucleolar amount of B23 was down-regulated with a
ratio of 0.59, while NDHII (DHX9/RHA) and PARP1
were up-regulated with a ratio of 11.9 and 4.29, respec-
tively (Additional file 2). The amount of B23, NDH II
and PARP1 in the nucleolar lyaste of sodium butyrate
treated cells was compared to control cells by Western
blotting as shown in Figure 3A. We found that the B23
protein level is indeed down-regulated while the protein
levels of PARP and NDH II are up-regulated following
the sodium butyrate treatment. To further characterize
the decrease of B23 in the nucleolus of senescent
NIH3T3 cells, we observed the subcellular distribution of
B23 in treated and control cells by immunofluoresence.
Figure 2 Nucleolar proteome following senescence induced by sodium butyrate treatment in NIH3T3 cells (A) SILAC labeling of
NIH3T3 cells to determine nucleolar protein dynamics in sodium butyrate induced senescent cells. The workflow shows SILAC labeling
of cells in a heavy (R6K4) media and a light (R0K0) media for 5 days followed by treatment of cells with vehicle or sodium butyrate. The cells
grown in the lighter media (R0K0) were treated with sodium butyrate for 4 days. Subsequently, the nucleolus from both control and sodium
butyrate treated cells were isolated. (B) Coomasie staining of the SDS PAGE gels of control and sodium butyrate treated nucleolar lysates from
cells grown in SILAC media. The protein nucleolar lysates were quantitated using Bradford-Lowry reagent and 50 ug of total nucleolar lysate
were run on a SDS-PAGE. Note the changes in the protein composition of control and treated nucleolar lysate. (C) Dynamic regulation of
nucleolar proteins identified from quantitative proteomics by using SILAC based LC MS/MS following senescence induced with sodium butyrate
in NIH3T3 cells. SILAC ratio was defined by the log2 of the averaged R0K0/R6K4 ratios of the peptides identified for each protein. (D) Functional
classification of 344 proteins identified from SILAC based mass spectrometry in sodium butyrate induced senescent NIH3T3 cell nucleoli. (E)
Analysis of the fold change of the proteins in the nucleolus following sodium butyrate induced senescence based on their cellular function.
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nucleolar staining by anti-B23 in sodium butyrate treated
NIH3T3 cells is clearly weaker than that in untreated
cells (Figure 3B). Interestingly, there is a corresponding
increase of B23 labeling in the nucleoplasm of the
sodium butyrate cells, which suggests that the observed
decrease in the abundance of nucleolar B23 may reflect a
re-distribution of this protein from the nucleolus to the
nucleoplasm.
Reorganization of the nucleolus after sodium butyrate
treatmet
From our proteomic analysis, we observed that there
was an upregulation in the proteins related to chromatin
remodeling following induction of senescence in
NIH3T3 cells with Sodium butyrate. To further study
this effect, we stained the control and Sodium butyrate
treated cells with DNA dye Hoechst 33342 and observed
the nuclei with high magnification under confocal
microscope. When the butyrate-treated NIH3T3 cells
were stained with DNA dye Hoechst 33342, compared
to control cells (Figures 4A, E, C 4G), we observed the
presence of chromatin within the nucleoli of many trea-
ted cells (Figures 4B, F, D, H). This probably reflects the
increase in abundance of histones and other chromatin-
related proteins as detected by MS. In untreated and
mock-treated NIH3T3 cells, clusters of chromatin cen-
ters (visualized by Hoechst staining) could be seen in
the interphase nucleus, frequently associated with the
nucleolar periphery, which are commonly observed in
mouse cells. The core of the nucleoli is generally free of
chromatin, an observation consistent with early electron
microscopy studies [39]. Within 2 days of sodium buty-
rate treatment, however, Hoechst-labeled chromatin is
found on the inside of some of the nucleoli of the trea-
ted NIH3T3 cells (Figure 4F). To quantitate the number
of nucleoli that display intranucleolar chromatin, we
counted 200 nucleoli in both controls, and 2 or 4 day
sodium butyrate treated cells. We observed that there is
about a 40% increase in the proportion of cells display-
ing nucleolar chromatin following 2 or 4 days of treat-
ment (Figure 4I).
Sodium butyrate-induced nucleolar organization does not
affect nucleolar RNA synthesis
Since heterochromatin is often associated with tran-
scriptional silencing, we asked if the sodium-butyrate-
induced accumulation of chromatin in the nucleolus is a
reflection of an inhibition of nucleolar transcription.
Sodium butyrate-treated and mock-treated NIH3T3
cells were pulsed with 5-FU and then immuno-cyto-
chemically labeled for transcription sites (Figures 4J-Q).
As shown in Figure 4N, there was no detectable differ-
ence in the amount of 5-FU incorporation in the
nucleolus after a sodium butyrate treatment, which indi-
cates that sodium butyrate does not affect the rate of
RNA synthesis in the nucleolus. The appearance of
chromatin inside the nucleolus and the re-distribution
of B23 suggest a general re-organization of the nuclear
structure as a result of the sodium butyrate treatment.
Figure 3 Validation of proteomic result (A) Western blotting analysis used to validate the mass spectrometric result. NIH3T3 cells were
vehicle or sodium butyrate treated for 4 days followed by isolation of nucleoli. The protein concentration was ascertained and then 10 ug of
total protein was run on an SDS-PAGE to compare the levels of B23, NDH II and PARP1 proteins. Western blotting was performed with anti-B23,
anti-NDH II and anti-PARP1 to validate the levels of these proteins following sodium butyrate induced senescence. (B) Indirect
Immunofluorescence showing B23 localization in control and sodium butyrate treated (4 days) NIH3T3 cells.
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systems
The c-Jun NH
2-terminal kinase (JNK) is a mitogen-acti-
vated protein kinase that has been implicated to be acti-
vated in response to stress in many cell lines, but
increasing evidence also suggests that JNK plays a role
in cell proliferation and survival [40] too. It has been
also demonstrated that in UV irradiated cells following
JNK activation, c-Jun translocates B23 out of the
nucleolus [41]. Since sodium butyrate induces an arrest
of NIH3T3 cells at G1, it is important to verify whether
the observed redistribution of B23 in the nucleolus in
sodium butyrate treated cells is a senescence-specific
event and not a collateral result of stress. To this end,
we examined the nucleolar abundance of B23 in serum-
starved NIH3T3 cells for 24 hours. A FACS analysis
showed that over 98% of the cells are blocked in the G1
phase following serum starvation (Additional files 3, A,
B). To investigate the level of B23 protein, we isolated
nucleoli from control and serum starved cells, and the
protein amount was quantitated by using the Bradford
method. Equal amounts of nucleolar protein were run
on an SDS-PAGE. A Western blotting analysis with an
anti-B23 antibody showed that there is no observable
alteration in the level of B23 protein in the serum
starved cells compared to the control (Additional file 3,
C). This result demonstrates that the down-regulation of
B23 protein levels in the nucleolus is not a general phe-
nomenon of the G1 cell cycle block, but a sodium buty-
rate specific effect.
Mitoxantrone (MTX) treated cells have been shown to
undergo genotoxic stress-induced senescence in fibro-
blast cell lines by many laboratories [42]. Since the cel-
lular target for MTX is different from sodium butyrate,
Figure 4 Analysis of chromatin organization in sodium butyrate induced senescent NH3T3 cells. (A-D) NIH3T3 cells were treated with
sodium butyrate for 2 or 4 days and then stained with Hoechst 33258 for visualizing chromatin. (E-H) is a magnified view of the field in boxes
in A-D respectively. (I) Quantitative analysis of the nucleoli in sodium butyrate treated cells with chromatin re-organized from outside to inside
the nucleolus. About 200 nucleoli were counted in the treated and control cells and the number expressed as a percentage of the nucleoli in
which chromatin was found to be inside the nucleoli. (J-Q) Assessment of in situ rRNA transcriptional sites in the 4 day sodium butyrate treated
senescent NIH3T3 cells by 5-fluorouridine labeling followed by staining with BrdU antibody (Red). (J-M) depicts control cells while (N-Q) depicts
sodium butyrate treated cells. The detailed magnified view of the areas in broken boxes is shown in M and Q.
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ment with a concentration that has been known to
induce senescence in cells. Nine days after the MTX
treatment, the NIH3T3 cells demonstrated senescent
morphology, with larger and flattened cells, and bigger
nuclei which were positive in the SA-b-gal assay (Fig-
ures 5A, B). We observed little toxicity, but also a
slower proliferation in the MTX treated NIH3T3 cells.
Upon a FACS analysis of the propidium iodide stained
MTX treated cells, we found 80% of the treated cells to
be blocked in the G2/M phase after 2 days and follow-
ing 9 days of treatment, a significant percentage (45%)
of the cells are still blocked in the G2 phase (Additional
file 4, A, B), in concurrence with the literature [43]. Fol-
lowing 9 days of MTX treatment of NIH3T3 cells, we
fractionated the cells and checked for purity of the pre-
paration by Western blotting using B23 (nucleolus),
lamin A/C (nucleus) and Actin (cytoplasm) as markers
(Additional file 4, C). We found that upon MTX treat-
ment, like sodium butyrate, leads to a redistribution of
B23 to the nucleoplasm (Figure 5C-H). The effect of
MTX treatment on the level of nucleolar B23 protein is
even more pronounced than sodium butyrate. Further-
more, a similar appearance of chromatin in the nucleo-
lus was also observed in MTX treated cells (arrow,
Figure 5G), which confirms that the observed re-organi-
zation of the nuclear structure in sodium butyrate trea-
ted cells is not a cellular response to particular
chemicals, but more likely a general reflection of
senescence.
To further confirm the observed nuclear re-organiza-
tion in senescent cells, we utilized an animal model of
aging. Mutations in LMNA have been shown to cause a
whole range of pre-mature aging diseases, like the
Hutchinson-Gilford progeria syndrome (HGPS), Wer-
ner’s syndrome (WRN) and cardiocutaneous progeria
syndrome (CCPS) [11,12,44-46]. Embryonic fibroblasts
derived from Lamin A knockout mice are a widely used
model system to study senescence [47,48]. To investi-
gate if MEFs derived from the knockout mice display
any changes in the B23 protein expression, we per-
formed immunostaining for B23 protein. As expected,
Figure 5 Effect of MTX treatment on B23 localization in NIH3T3 cells (A, B) Morphological changes and SA-b-gal staining of NIH3T3
cells when treated with 1 uM MTX for 9 days. The blue coloration is an indication of senescence. (C-H) B23 protein staining in MTX treated
NIH3T3 cells. The cells were also counter stained with Hoechst 33258 to stain DNA. The arrows in G point to chromatin foci inside the nucleolus
of MTX treated cells. The bars represent 10 μm.
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B23 protein level in the control and knockout MEFs
(Figure 6A), but the distribution of B23 in the two com-
pared cell lines are significantly different. We found that
the MEFs from knockout mice display diffused staining
in the nucleus for B23 (Figure 6G-K) as opposed to
nucleolar staining in the control cells (Figure 6B-F),
with the appearance of chromatin in the nucleoli (Figure
6K), which is consistent with our data in cells induced
by either sodium butyrate or MTX. Taken together, the
redistribution of B23 and heterochromatin was observed
in the nucleoli of senescent cells irrespective of the sti-
muli, and this suggests that it is a senescence specific
effect and not due to the agent used to induce
senescence.
There have been sporadic reports on the presence of
condensed chromatin in the proximity of the nucleolus.
For example, in human lymphocytes, it has been
observed that some chromatin inclusions reside close to
the fibrillar center in the nucleolus [49]. Although
dramatic heterochromatin reorganizations, including the
formation of SAHF, have been observed in senescent
cells [50], but these structures are not reportedly within
the nucleolus. Interestingly, we observed that in sodium
butyrate treated mouse fibroblast cells, the chromatin re-
organizes and relocates inside the nucleolus. Histone
H1x exhibits a cell-cycle-dependent change in its nuclear
distribution and accumulates in the nucleolus during the
G1 phase when treated with sodium butyrate and it was
evenly distributed in the nucleus during the S phase and
G2 [51]. In our proteomic screening of sodium butyrate
treated mouse fibroblast senescent cells, we observed a
general accumulation of histones in the nucleolus. We
observed the same phenomenon in MTX-treated senes-
cence cells, which is a G2 cell cycle block. We similarly
also observed a chromatin relocation to the nucleolus in
the primary Lmna-/- mouse cells which is a well known
mouse model system for studying pre-mature aging. So,
we believe that it is not an effect of a cell cycle block, but
a senescence specific effect, at least in mouse cells.
Figure 6 Comparison of the distribution of B23 protein in primary fibroblast cells from lamin -/- and lamin +/+ mice (A) lamin +/+
and lamin -/- cells were lysed in RIPA buffer and Western blotting performed with antibody for lamin A/C, B23 or actin. The lysates
were quantitated using Bradford-Lowry reagent and then 10 ug of lysate was run on a SDS-PAGE. (B-K) lamin A +/+ and lamin A-/- cells were
grown on coverslips and then stained for B23 protein. The cells were also counter stained with Hoechst 33258 to stain DNA. The arrows in (E)
and (J) point to the representative nucleolar staining of B23 in Lamin A +/+ and Lamin A -/- cells respectively. The bars represent 10 μm.
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Page 10 of 13B23 is a nucleolar phospho-protein, which plays a role
in cellular proliferation, cell survival, ribosomal biogen-
esis, aiding in ribosome assembly [52] and also surveil-
lance of oncogenic insults in cells [53]. In the present
s t u d y ,w ef o u n dt h a tu p o ns o d i u mb u t y r a t et r e a t m e n t ,
the ribosomal biogenesis in the nucleolus is down-regu-
lated with B23 being relocated from the nucleolus to the
nucleoplasm of mouse fibroblast. Apart from its prolif-
erative and nucleolar role, several lines of evidence indi-
cate that B23 can be used as a biomarker for
hematopoietic leukaemia [54]. Several point mutations
on B23 have been detected in Acute Myelogenous Leu-
kemia (AML) patients that also have been shown to
translocate B23 protein from nucleolus to the nucleus
and cytoplasm. It has also been shown that when cells
are stressed with UV irradiation, B23 moves away from
the nucleolus [41]. Hence, B23 may play a central role
in influencing cellular proliferation and senescence in
mammalian cells.
Our study is the latest addition to a growing body of
literature on the use of SILAC-based proteomics to
examine nucleolar proteome dynamics after metabolic
perturbations [30,31,55,56]. These studies build a pic-
ture of the divergent responses of the nucleolar com-
position to different treatments. The change in the
nucleolar proteome in senescence reported here is dif-
ferent from each of the published studies, indicating
that different treatments are interpreted by mammalian
cells differently, and can induce specific biochemical
responses in the nucleoli. For example, the redistribu-
tion of B23 from the nucleolus, observed in this study
and other studies as well [41,57], was not observed in
etoposide treatment [53] regardless of the p53 back-
ground of the cells studied [56]. This suggests that the
B23 re-localization may be a reflection of a certain
subset of growth inhibition, including senescence, and
it is important to consider the global changes of
nuclear proteins, instead of just one or two marker
proteins.
Conclusion
In conclusion, this study describes for the first time
the global change in the nucleolar proteome in
response to induced senescence in mammalian cells. It
provides the foundation on which future work on the
role of nucleoli and nuclear organization in senescence
can be built. In particular, the combined redistribution
of B23 and chromatin in the nucleus found in all three
in vitro models of senescence used in this study sug-
gests a possible morphological signature of senescence.
The functional significance of this redistribution of
nucleolar protein will be a subject of future
investigation.
Additional material
Additional file 1: Isolation of nucleolus in NIH3T3 cells (A)
Microscopic analysis of an aliquot of the nuclei and nucleolus
during the isolation procedure to assess the integrity of the nuclear
and nucleolar membrane (B) Western blotting analysis of the
nucleolar, nuclear and cytosolic lysate with a specific antibody
towards a nucleolar (anti-fibrillarin), nucleoplasmic (anti-Lamin A/C)
or cytoplasmic (anti actin) protein marker to test the purity of the
cellular fractions. The protein concentration of the lysates were
determined using Bradford-Lowry reagent and 10 ug of lyastes from
each fraction were run on a SDS-PAGE.
Additional file 2: A list of 344 proteins detected by Quantitative
Mass spectrometry showing the SILAC ratio (log 2) of nucleolar
proteins in NIH3T3 cells following Sodium Butyrate treatment. This
table lists the accession number with Gene name of 344 proteins
identified by Mass spectrometer and generated by using ProteinCenter
(Proxeon Bioinformatics), a proteomics data mining and management
software which converted protein IDs to gene symbols and perform
initial gene ontology characterization.
Additional file 3: Down-regulation of B23 protein level during
senescence is not a result of cell cycle block. (A) NIH3T3 cells were
grown either in 10% serum or no serum for 24 hrs. The control or
starved cells were stained with propidium iodide to analyze the DNA
content by a FACS analysis. (B) The percentage of cells in different
phases of the cell cycle with or without serum starvation was analyzed
by using ModFit V 3.0 software. (C) NIH3T3 cells were fractionated and
pure nuclei from the control and serum starved cells were isolated. The
total protein concentration was measured using Bradford-Lowry reagent
and equal amounts (10 ug) of nucleoli from the control and serum
starved cells were ran on an SDS-PAGE to assess the level of B23 protein
during G1 cell cycle block.
Additional file 4: MTX treatment in NIH3T3 cells (A) A FACS analysis
of the control, 2 days or 9 days of MTX treated cells stained with
propidium iodide. (B) The percentage of untreated or MTX treated
NIH3T3 cells in different phases of the cell cycle analyzed by using
ModFit V 3.0 software. (C) Western blotting analysis of the nucleolar,
nucleoplasmic and cytosolic lysate from MTX (9 days) treated NIH3T3
cells with a specific antibody towards a nucleolar (anti-B23),
nucleoplasmic (anti-Lamin A/C) or cytoplasmic (anti actin) protein marker.
The protein concentration of the lysates from the different cellular
fraction were determined using Bradford-Lowry reagent and 10 ug of
lyastes from each fraction were run on a SDS-PAGE.
Abbreviations
B23: (Nucleoplasmin); MTX: (Mitoxantrone); SA-βgal: (Senescence Associated
βgalactosidase); 5-FU: (5-Fluorouridine).
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